Self-medication with antibiotics in Lithuania

International Journal of Occupational Medicine and Environmental Health

Volumn 19, Issue 4, 2006, Pages 246-253

  Berzanskyte, Ausra ^a   Valinteliene, Rolanda ^a   Haaijer Ruskamp, Flora M ^b   Gurevicius, Romualdas ^a   Grigoryan, Larissa ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antibacterial drugs; Antibiotics; Intended self medication; Self medication

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; COMMUNITY CARE; CONTROLLED STUDY; DRUG USE; HEALTH BEHAVIOR; HEALTH CARE; HEALTH EDUCATION; HUMAN; LITHUANIA; PATIENT EDUCATION; PHARMACY; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; SELF MEDICATION; TONSILLITIS; TREATMENT INDICATION;

EID: 33846805743     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10001-006-0030-9     Document Type: Article

References (30)

1. Smith RD, et al. Cost effectiveness analysis: interventions against antimicrobial resistance. Interim report to the Global Forum for Health Research; 2001.
2. Goossens H, Ferech M, Vander-Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579-87.
3. Davey P, Brown E, Fenelon L, Finch R, Gould I, Holmes A, et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis 2006;12(2):211-6.
4. Picazo JJ, Perez-Cecilia E, Herreras A, Grupo DIRA en Atencion Primaria. Respiratory infections outside the hospital. DIRA study. Enferm Infecc Microbiol Clin 2003;21(8):410-6.
5. Jouhnston AM. Use of antimicrobial drugs in veterinary practice. Br Med J 1998;317:665-7.
6. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen LK. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8(3):278-82.
7. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002;8(4):347-54.
8. Samaranayake LP, Johnson NW. Guidelines for the use of antimicrobial agents to minimise development of resistance. Int Dent J 1999;49(4):189-95.
9. Okumura J, Wakai S, Umenai T. Drug utilisation and self-medication in rural communities in Vietnam. Sci Med 2002; 54(12):1875-86.
10. Harbarth St, Albrich W, Buisson CB. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: A sociocultural perspective. Emerg Infect Dis 2002;8(12):1460-7.
11. Stefanovič A, Kalibatas J, Žagminas K, Jurkuvėnas V. Epidemiological peculiarities of prescription of antimicrobial agents and application of microbiological tests in outpatient clinics of Lithuania. Visuomenės Sveikata 2003;3(22):10-7 [in Lithuanian].
12. Orero A, Gonzales J, Prieto J. Antibiotics in Spanish households. Medical and socioeconomic implications. Med Clin 1997;109:782-5.
13. Contopoulos-Ioannidis DG, Koliofoti ID, Koutroumpa IC, Giannakakis IA, Ioannidis JP. Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: a randomized trial. Clin Infect Dis 2001;33:76-82.
14. Borg MA, Scicluna EA. Over-the-counter acquisition of antibiotics in the Maltese general population. Int J Antimicrob Agents 2002;20:253-7.
15. Stratchounski LS, Andreeva IV, Ratchina SA, Galkin DV, Petrotchenkova NA, Demin AA, et al. The inventory of antibiotics in Russian home medicine cabinets. Clinic Infect Dis 2003;37:498-505.
16. Standard Occupational Classification 2000 (SOC2000) [cited 2006 Oct 3]. available from: http://www.statistics.gov.uk/methods_quality/ns_sec/ downloads/SOC2000.doc.
17. Kypri K, Stephenson S, Langley J. Assessment of nonresponse bias in an internet survey of alcohol use. Alcohol Clin Exp Res 2004;28(4):630-4.
18. Grigoryan L, Haaijer-Rysjamp FM, Burgerhof JG, Mechtler R, Deschepper R, Tambic-Andrasevic A, et al. Self-medication with antibiotics in the general population: a survey in nineteen European countries. Emerg Infect Dis 2006;12(3):452-9.
19. Shankar PR, Kumar P, Theodore AM, Partha P, Shenoy N. A survey of drug use patterns in western Nepal. Singapore Med J 2003;44(7):352-6.
20. Halfvarsson J, Heijne N, Ljungman P, Ham MN, Holmgren G, Tomson G. Knowing when but not how! Mothers' perceptions and use of antibiotics in a rural area of Vietnam. Trop Doct 2000;30(1):6-10.
21. Branthwaite A, Pechere JC. Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res 1996;24(3):229-38.
22. Richman PB, Garra G, Eskin B, Nashed AH, Cody R. Oral antibiotic use without consulting a physician: A survey of ED patients. Am J Emerg Med 2001;19(1):57-60.
23. McKee MD, Mills L, Mainous AG 3rd. Antibiotic use for the treatment of upper respiratory infections in a diverse community. J Fam Pract 1999;48(12):993-6.
24. Beržanskytė A, Šakelytė R, Valintėlienė R. Self-medication with antibiotics in Lithuanian population. Visuomenės Sveikata 2004;4(27):13-8 [in Lithuanian].
25. Cagri Buke A, Ermertcan S, Hosgor-Limoncu M, Ciceklioglu M, Eren S. Rational antibiotic use and academic staff. Int J Antimicrob Agents 2003;21(1):63-6.
26. Bozdogan B, Appelbaum PC, Kelly LM, Hoellman DB, Tambic-Andrasevic A, Drukalska L, et al. Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers. Clin Microbiol Infect 2003;9(7):653-61.
27. Bozdogan B, Appelbaum PC, Kelly LM, Hoellman DB, Tambic-Andrasevic A, Drukalska L, et al. Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe. Clin Microbiol Infect 2003;9(7):741-5.
28. Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Tambic Andrasevic A, et al. Susceptibility to Telithromycin in 1011 Streptococcus pyogenes isolates from ten Central and Eastern European Countries. Antimicrob Agents Chemother 2002;46(2):546-9.
29. Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Tambic Andrasevic A, et al. Susceptibilities to Telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from ten Central and Eastern European Countries. Antimicrob Agents Chemother 2002;46(2):371-7.
30. McNulty CA. Optimising antibiotic prescribing in primary care. Int J Antimicrob Agents 2001;18(4):329-33.